Letter by Kataoka et al Regarding Article, “Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)”
Circulation · 2023
DOI: 10.1161/circulationaha.123.065320 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2023. Verfasst von Naoya Kataoka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine, University of Toyama, Japan. Hauptthemen laut MEDLINE: Brugada Syndrome, Catheter Ablation. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Second Department of Internal Medicine, University of Toyama, Japan.
ORCID-Profile: Naoya Kataoka, Teruhiko Imamura
Zitieren
APA
Kataoka, N., Imamura, T., & Kinugawa, K. (2023). Letter by Kataoka et al Regarding Article, “Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)”. Circulation. https://doi.org/10.1161/circulationaha.123.065320
Vancouver
Kataoka N, Imamura T, Kinugawa K. Letter by Kataoka et al Regarding Article, “Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)”. Circulation. 2023. doi:10.1161/circulationaha.123.065320
BibTeX
@article{Kataoka2023,
author = {Kataoka, Naoya and Imamura, Teruhiko and Kinugawa, Koichiro},
title = {Letter by Kataoka et al Regarding Article, “Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)”},
journal = {Circulation},
year = {2023},
doi = {10.1161/circulationaha.123.065320}
}
EUVIMED